Sascan Meditech, developed a unique device to detect oral cancers early

▴ Sascan Meditech, developed a unique device to detect oral cancers early
Sascan Meditech Pvt Ltd has developed a unique device called ‘OralScan’ which could detect oral cancers early

Sascan Meditech Pvt Ltd, a startup company, which incubated at Technology Business Incubator of Sree Chitra Tirunal Institute for Medical Sciences & Technology is launching OralScan which is a Make- in- India initiative with seed funding from the scheme National Initiative for Developing and Harnessing Innovations (NIDHI) of the Department of Science & Technology (DST).

Oral scan was designed and developed entirely in India. According to Dr Subhash Narayanan, CEO of Sascan, oral cancer is a growing concern in India with more than 80,000 fresh cases reported each year.

The disease has a high mortality rate because of the delay in detection. Current practice relies on oral examinations using a torch light to detect early stage cancers of the oral cavity.

Various studies have demonstrated that this screening technique is not very reliable and often oral potentially malignant lesions (OPMLs) go undetected in the early stages. Even experienced clinicians find it difficult to locate the optimal site for a biopsy based on conventional oral examination.

This leads to multiple biopsies, increased expenditure and false negative reports which can delay diagnosis and outcome.

It is in this context that the OralScan, a handheld imaging device developed by Sascan for screening, detection of OPMLs and biopsy guidance becomes relevant. A software assists the surgeon in taking biopsy from the most appropriate site which is likely to confirm the diagnosis of malignancy.

The device will be marketed at a price of Rs 5.9 Lakhs. This will be a one- time investment for hospitals and laboratories without any additional costs of consumables. OralScan has also undergone multicentric trials covering 6 hospitals across the country.

Sascan, has already obtained ISO 13485 certification Indian patent has been granted for the technology and US patent has been filed. OralScan has also undergone multicentric trials covering 6 hospitals across the country.

Tags : #SascanMeditech #LatestNewsonSascanMeditech28thOct #LatestNewsonOralCancers28thOct #LatestPharmaNews28thOct #India #SreeChitraTirunalInstituteforMedicalSciencesTechnology #MakeinIndia #DrSubhashNarayanan #OralCavity #MortalityRate #OralCancers

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

1,031 new cases of COVID-19 confirmed in Himachal PradeshNovember 25, 2020
Cooking with wood may cause lung damageNovember 25, 2020
More than 56 lakh sample tests for COVID-19 conducted in OdishaNovember 25, 2020
COVID-19 recovery rate in Bihar improves to 97.30 pctNovember 25, 2020
Green Mediterranean (‘green Med’) diet may be even better for healthNovember 25, 2020
Chhattisgarh: Intensive Covid screening of all passengers to be done mandatorily at airportsNovember 25, 2020
New guidance issued on policies to protect populations in vulnerable situations in context of COVID-19November 25, 2020
Life Extension® Launches Bloat Relief Formula.November 25, 2020
Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR TestingNovember 25, 2020
Bristol Myers Squibb Receives European Commission Approval for OpdivoNovember 25, 2020
QualTex Laboratories adds Ortho Diagnostics VITROS® Anti-SARS-CoV-2 IgG assayNovember 25, 2020
China resorts to rigorous measures after multiple locally transmitted coronavirus cases detected in three citiesNovember 25, 2020
National COVID-19 recovery rate reaches 93.72 pctNovember 25, 2020
Nearly 11,60,000 COVID samples tested in country in last 24 hoursNovember 25, 2020
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysisNovember 25, 2020
Taking the Pill may cut risk of severe asthma bouts in women of reproductive ageNovember 25, 2020
Multilateral cooperation is key to overcoming global challenges such as COVID-19: Dr Harsh VardhanNovember 25, 2020
Polaryx Therapeutics receives both rare pediatric disease and orphan drug designations from US FDANovember 25, 2020
Panaxia and Neuraxpharm expand strategic collaboration to France with medical cannabisNovember 25, 2020
6,224 new cases of COVID-19 detected in DelhiNovember 25, 2020